The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients

Journal Article Corrected proof The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients Get access Antonius T Otten, MD, Antonius T Otten, MD Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands Address correspondence to: Antonius T. Otten, MD, Department of Gastroenterology and Hepatology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands, Tel: +31 50 361 26 20, (a.t.otten@umcg.nl). https://orcid.org/0000-0001-8168-5694 Search for other works by this author on: Oxford Academic PubMed Google Scholar Gerard Dijkstra, MD, PhD, Gerard Dijkstra, MD, PhD Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar Marijn C Visschedijk, MD, PhD, Marijn C Visschedijk, MD, PhD Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar Arno R Bourgonje, MD, PhD Arno R Bourgonje, MD, PhD Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsThe Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Inflammatory Bowel Diseases, izad144, https://doi.org/10.1093/ibd/izad144 Published: 31 July 2023